SC 13G
KARYOPHARM THERAPEUTICS INC.
- Company
- Karyopharm Therapeutics Inc.
- Filed
- February 14, 2020
- Accession Number
- 0000902664-20-001123
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →